References
- Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 (2006), Available from: http://ctep.cancer.gov
- Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. https://doi.org/10.1016/j.ejca.2008.10.026
-
Gao YH, Dai XH, Chen GL,et al (2003). A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W.Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides
$(Ganopoly^{(R)})$ in patients with advanced lung cancer. Int J Med Mushr, 5, 369-81 -
Gao YH, Zhou SF, Jiang WQ,et al (2003). Effects of
$Ganopoly^{(R)}$ (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest, 32, 201-15. https://doi.org/10.1081/IMM-120022979 - Jin X, Ruiz Beguerie J, Sze DM, Chan GF (2012). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev, 6, CD007731.
- Joseph S, Sabulal B, George V, Antony KR, Janardhanan KK (2011). Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm, 61, 335-42.
- Li P, Deng YP, Wei XX, Xu JH (2013). Triterpenoids from Ganoderma lucidum and their cytotoxic activities. Nat Prod Res, 27, 17-22. https://doi.org/10.1080/14786419.2011.652961
- Martinez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF (2011). Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer. Nutr Cancer, 63, 1085-94. https://doi.org/10.1080/01635581.2011.601845
- Wu G, Qian Z, Guo J, et al (2012). Ganoderma lucidum extract induces G1 cell cycle arrest, and apoptosis in human breast cancer cells. Am J Chin Med, 63, 631-42.
- Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S (2007). Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai, 90, 179-81.
- Wanachiwanawin D, Piankijagum A, Chaiprasert A, et al (2006). Ganoderma lucidum: a cause of pseudoparasitosis. Southeast Asian J Trop Med Public Health, 37, 1099-102.
- Zhao, Ye G, Fu G, et al (2011). Ganoderma lucidum exerts antitumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol, 38, 1319-27.
Cited by
- for Cancer Treatment vol.14, pp.3, 2015, https://doi.org/10.1177/1534735414568721
- Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo vol.50, pp.5, 2017, https://doi.org/10.3892/ijo.2017.3939
- Ganoderma: A Cancer Immunotherapy Review vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.01217